1 torical controls that developed LSCD, pannus
was noted in 1 (13%) and pseudopterygium extending onto
2 Among the 19 laser-treated eyes, leakage
was noted in 1 eye, shunts and tangles were noted in 3 e
3 eyes and diffuse choroidal vascular dilation
was noted in 1 eye.
4 ntact with shared resources, as transmission
was noted in 1 of 4 of the mallards tested.
5 d in 22 patients (44%), neovascular glaucoma
was noted in 1 patient (2%), and there were no cases of
6 rom conscious sedation to general anesthesia
was noted in 102 of 1737 (5.9%) of conscious sedation ca
7 A major discrepancy with the gold standard
was noted in 12 (6%) cases identified by PMCTA, and in n
8 (blaTEM-1 gene) and azithromycin resistance
was noted in 12.7% of Salmonella Typhimurium isolates, a
9 Hair loss on the scalp
was noted in 120 (96%), arms and legs in 52 (42%), and e
10 Acute clinical usefulness
was noted in 13 (65%) of 20 infants with a STATseq diagn
11 Serious adverse events
were noted in 13 (7%) of 200 patients in the BMS-663068
12 Dose-related worsening of glycemic control
was noted in 14.5% of patients who received relamorelin;
13 In phase 2, objective responses
were noted in 14 of 22 (63.6%, 95% CI 41.8-81.3) patient
14 The KRAS oncogenic driver mutation
is noted in 15% to 25% of patients with NSCLC.
15 anaged in a hospital setting, VF progression
was noted in 15.8%, and the overall rate of VF loss was
16 ed an objective response: complete responses
were noted in 15 (52%) patients and partial responses in
17 Seroconversion for type 2
was noted in 16 infants (9%, 5-14) on bOPV short, 29 (16
18 Bacterial growth of more than 0 CFU
was noted in 16.1% duodenoscopes in the sHLD group, 16.0
19 Seroconversion for type 3
was noted in 175 infants (94%, 90-97) on bOPV short, 176
20 Persistent electric isolation
was noted in 178 of 258 (69%) PVs.
21 - 0.5 (range = 1-2); bilateral retinal tears
were noted in 18.2% of eyes; 86.4% were myopic eyes (p =
22 Complete endoscopic healting
was noted in 19 (50%, 34-66) of 38 patients.
23 Vision loss
was noted in 19.2% of eyes, with an incidence for MVL of
24 Intracranial hemorrhage
was noted in 2 neonates (nadir platelet counts were 135
25 Bacterial growth or 10 or more CFU
was noted in 2.3% of duodenoscopes in the sHLD group, 4.
26 Stent fractures
were noted in 2 patients at 1 year and 11 patients at 2
27 Other variants
were noted in 2.6% of subjects.
28 Bridging fibrosis
was noted in 20.6% of patients but no patients had cirrh
29 anning, nutrition, and immunisation projects
were noted in 2011 and 2012.
30 he number of children born with microcephaly
was noted in 2015 in regions of Brazil with high transmi
31 Postoperative complications
were noted in 21.6% of patients varying from 2.1% follow
32 Diagnosed and self-reported allergies
were noted in 21.9% and 45.5% of participants, respectiv
33 Tumour downstaging after surgery
was noted in 22 (71%) of 31 patients; nine (29%) of 31 p
34 nts (52%), progression or new-onset cataract
was noted in 22 patients (44%), neovascular glaucoma was
35 Limited visual impairment
was noted in 22.3%, low vision in 29.7%, and legal blind
36 Serious treatment-emergent events
were noted in 22 (19%) patients in treatment group A and
37 [20%]) groups, qAF8 levels within the 95% PI
were noted in 22 patients (79%; 95% CI, 60% to 90%) and
38 Some suggestion of clinical activity
was noted in 23 (49%) of 47 patients with haematological
39 Minimal responses
were noted in 23 (6%) patients in the panobinostat group
40 ecommended phase 2 dose, objective responses
were noted in 23 of 42 activity-evaluable patients with
41 Shockable arrest rhythms
were noted in 23.3% of patients.
42 Extremely high CF >/=100g
was noted in 24 points (0.7%).
43 Investigator-assessed objective responses
were noted in 24 (55%) patients, with a confirmed comple
44 Iris stromal atrophy
was noted in 26 patients (52%), progression or new-onset
45 Advanced fibrosis
was noted in 26.8%, whereas 5.4% had cirrhosis but were
46 Transient ellipsoid zone changes
were noted in 26% of treated eyes (n = 15), of which 14
47 re autoimmune and inflammatory complications
were noted in 26.2% of patients, with a risk of onset th
48 9%) patients; near complete (>95%) occlusion
was noted in 27 of 44 (61%) patients.
49 A positive circumferential resection margin
was noted in 2859 (17.2%) of the 16,619 patients include
50 PCV eyes, focal choroidal vascular dilation
was noted in 3 eyes and diffuse choroidal vascular dilat
51 LTP within 12 months after RF ablation
was noted in 3% (95% CI: 0, 9) of necrotic CLMs with mar
52 akage was noted in 1 eye, shunts and tangles
were noted in 3 eyes, and macular abnormalities were not
53 e noted in 3 eyes, and macular abnormalities
were noted in 3 eyes.
54 Active anterior chamber inflammation
was noted in 30 eyes (40%) at baseline and in 16 (34%),
55 raphic demonstration of peripheral ischemia,
was noted in 30 eyes (91%) in the bevacizumab group, at
56 32.0%) same eyes (P = .90); and plus disease
was noted in 30 of 191 (15.7%) early eyes and 45 of 200
57 Additional ocular abnormalities
were noted in 301 eyes (24%).
58 Overall responses
were noted in 31 patients (29.2%, 95% CI 20.8-38.9)-thre
59 Frailty
was noted in 323 patients (57.3%).
60 TIPS completion, persistence of MPV thrombus
was noted in 33 of 43 (77%) cases.
61 Abnormal ascending aortic area/height ratio
was noted in 33%; 44% underwent ascending aortic surgery
62 Severe IFIS
was noted in 34.3% (24/70) of the tamsulosin eyes and in
63 Cortical lesions
were noted in 35 of 36 participants (97%), with a median
64 Abnormal findings
were noted in 36.8% of patients and there was >90% agree
65 Discrete areas of flow loss
were noted in 37.8% (31/82) of eyes overall and were com
66 Serious adverse events
were noted in 41 (41.4%, 95% CI 31.6-51.8) of 99 RTS,S/A
67 ction/disseminated intravascular coagulation
was noted in 43 patients (5.6% of total; 18-75 years old
68 Clinical recurrence after treatment
was noted in 44 infected ulcers (63%), after a median in
69 oronary adventitia, but not media or intima,
was noted in 44% of lesions.
70 Haab's striae
were noted in 44.8% of eyes (26/58 eyes) and were most f
71 Single duct opening
was noted in 440 (75.34%), two duct openings in 135(23.1
72 decrease in prostate-specific antigen levels
was noted in 45 of 56 patients (80.4%).
73 Paradoxical response
was noted in 453 (5%) of 9986 patients and the frequency
74 Congenital heart anomalies
were noted in 47% (8/17) of NOTCH1-positive probands and
75 v-Lesions
were noted in 49 specimens (7%) and were usually mild (v
76 Gastrointestinal angiodysplasia
was noted in 5 of 6 bleeding patients with dysfunctional
77 y with lobectomy, no significant differences
were noted in 5-year freedom from recurrence (70% v 71%,
78 ype of cataract was nuclear sclerosis, which
was noted in 51% of cases.
79 Azoospermia
was noted in 53 (25%) of 214 participants, oligospermia
80 Treatment-related adverse events
were noted in 59 (22%) of 271 patients in the naldemedin
81 Progression of IF/TA from implantation
was noted in 6 (24%) of 25 ABOi and 6 (17.6%) of 34 ABOc
82 Gastrointestinal bleeding
was noted in 6 of 24 patients with aortic prosthesis dys
83 y, transient clinical improvement with fever
was noted in 6 patients.
84 itivity was not compromised: true bacteremia
was noted in 65/904 (7.2%) ISDD vs 69/904 (7.6%) standar
85 ian's diagnosis of asthma/recurrent wheezing
was noted in 67%, and 51% were receiving regular prevent
86 Sustained haematological improvement
was noted in 72 (79%) of 91 patients with any baseline c
87 d patients an improvement of the retinopathy
was noted in 73% (27/37), no change in 16.2% (6/37) and
88 Subprophylactic anti-Xa troughs
were noted in 73 of 87 patients (83.9%) in the adjustmen
89 Kidney recovery
was noted in 78.8% of the cases.
90 rty-day device safety, success, and efficacy
were noted in 79.1%, 89.9%, and 84.9% of patients, respe
91 ian, 18 mmHg; range, 11-30 mmHg) and hyphema
was noted in 8 eyes (8/21, 38%).
92 Complete resolution of OSSN
was noted in 82% of patients (36/44); 18% (8/44) were co
93 Moderate/severe transvalvular regurgitation
was noted in 89 patients (3.7%) after TAVR and increased
94 formance Category 1-2) at hospital discharge
was noted in 9% of patients with myoclonus, less frequen
95 Trifurcation pattern
was noted in 9.3% of subjects.
96 Complications
were noted in 9.1% of the patients.
97 Viral suppression at week 48
was noted in 932 (97%) patients assigned to the tenofovi
98 Moderate to severe periodontitis
was noted in 98% of patients with RA and 82% of the HC g
99 Poor outcomes
are noted in a majority of very premature (<25 weeks ges
100 CASE 3
was noted in a 4-year-old girl.
101 CASE 2
was noted in a 6-year-old boy.
102 lthough significantly reduced mineralization
was noted in Abcc6(-/-) mice expressing human ENPP1, sma
103 Additionally, no major differences
were noted in AEs occurring in on-label vs off-label ica
104 Significant differences
were noted in age, relative cerebral blood volume (rCBV)
105 Although microglia activation has
been noted in all types of psychiatric disorder, no asso
106 follow-up CT, restoration of leaflet motion
was noted in all 11 patients who were receiving anticoag
107 r focally increased (18)F-florbetapir uptake
was noted in all AL and ATTR samples and in none of the
108 nge in central foveal thickness, improvement
was noted in all genotype groups, but reduction after tr
109 The reduction in risk
was noted in all populations except Latinos and was sign
110 Transient rVSV viremia
was noted in all the vaccine recipients after dose 1.
111 Transient subfoveal fluid accumulation
was noted in all these patients with vitreomacular relea
112 Residual matrix particles
were noted in all examined groups at both time points, w
113 improvements in PROs of +5.3 to +16.0 points
were noted in all PROs except for role emotional, mental
114 dent reductions in mean Lp(a) concentrations
were noted in all single-dose IONIS-APO(a)-LRx groups at
115 men (71.4%) and white (79.6%), respectively,
were noted in all years.
116 Similar findings
were noted in analyses of survival with functional recov
117 Similar results
were noted in analyses stratified on severe aplastic ane
118 er acute inflammation nor mineralized tissue
was noted in any of the subcutaneous specimens, whereas
119 Significant center-level heterogeneity
was noted in BMI of accepted donors; the MOR varied from
120 dependent selective cytotoxicity by OSU-T315
is noted in both CLL-derived cell lines and primary CLL
121 A fully developed CNV complex
was noted in both Cd46(-/-) and WT mice at day 7; howeve
122 Persistent RAGE upregulation
was noted in both the LD and HD groups until day 14.
123 However, repression
was noted in both wildtype and Ppp1r15a deleted cells an
124 activities of beta-1,3-glucanase, chitinase
were noted in both cultivars.
125 Although elevated local Th1 and Th17 cells
were noted in both eosinophilic and noneosinophilic CRSw
126 ids as well as trans- and cis-beta-carotenes
were noted in both the raw and boiled potatoes.
127 in key antioxidants such as glutathione has
been noted in brain tissue undergoing oxidative stress i
128 onic itch patients, versus healthy controls,
was noted in brain regions related to motor control and
129 = 1.76, 95% confidence interval: 1.35-2.29)
was noted in CAMP Caucasians.
130 ids, flavonols, anthocyanins and carotenoids
was noted in carrot roots directly after the harvest as
131 Likewise, increased CD162 and MPO expression
was noted in CD14(++)CD16(-) classical monocytes.
132 ated enhancements in ROS signal transduction
are noted in cells from patients with Crohn's disease.
133 Two deaths
were noted in chart review--one from respiratory failure
134 up-regulation of C3 and CFB mRNA expression
was noted in chemically induced mouse cSCCs, compared to
135 whereby an increasingly higher risk for OCD
was noted in children with a shorter gestational age and
136 Recently, ILC2s enrichment
was noted in chronic rhinosinusitis (CRS) patients; howe
137 Although minor differences
were noted in clinical and concurrent validators, no cha
138 damage, and inflammatory cytokine expression
were noted in colon specimens of the mice with PPI expos
139 No significant differences
were noted in colour of the samples.
140 an increase in cells containing micronuclei
was noted in comparison with controls.
141 and lower permeability-surface area product
were noted in comparison to volunteer livers (P < 0.05).
142 No significant differences
were noted in concomitant medications, laboratory abnorm
143 wever, significantly lower LA and BWT scores
were noted in CT images of MSC-treated animals compared
144 The greatest geometric means
were noted in dentine erosion for complexity and dentine
145 However, a slower subunit exchange
is noted in deuterated solvent, reflecting the poorer so
146 larger increases in OS between these periods
were noted in distant-stage gastrointestinal NETs (HR, 0
147 Several differences
were noted in distribution of cardiac structure and volu
148 (p = 0.01 for both eyes) while no worsening
was noted in either the lens or punctal plugs groups.
149 no significant effects on brain MRI measures
were noted in either group (mean T2 lesion volume change
150 No adverse events
were noted in either group.
151 No new safety signals
were noted in eligible patients and the safety profile i
152 200, random appearance of testicular atrophy
was noted in exposed offspring, and limited changes in o
153 Fewer complications
were noted in eyes receiving sclerostomy (5/29, 17.2%) a
154 or increase in peripheral anterior synechiae
were noted in eyes that underwent SLT.
155 ifferences between groups or testing periods
were noted in fasting and/or postprandial concentrations
156 um, P < .01) eyes, but no significant change
was noted in fellow unaffected eyes.
157 d transcripts for inflammatory gene products
were noted in fetal beta-cells.
158 Preliminary clinical efficacy
was noted in five patients (two partial response, three
159 19 grade 3 or higher adverse effects
were noted in five (42%) patients, with 14 occurring in
160 Congenital heart defects
were noted in four of the five affected individuals, and
161 roup at both time points, whereas less BV/TV
was noted in GDBM group at day 14.
162 ; however, greater (3)He ventilation defects
were noted in girls.
163 nd significantly greater collagen deposition
was noted in group PP relative to groups PR and PH at 4
164 r, differences in the function of iNKT cells
were noted in group 2, in which an increase in IFN-gamma
165 In 2(nd) and 4(th) instars, synergy
was noted in H. bacteriophora + B. bassiana combinations
166 Higher rates of local recurrence
were noted in HCC patients, which may reflect underlying
167 d year of study publication, inconsistencies
were noted in healthcare professionals' physical examina
168 s of Mycobacterium tuberculosis transmission
are noted in high burden settings and a renewed focus on
169 At baseline, more impairment in PRO scores
was noted in HIV/HCV-coinfected patients, compared with
170 Significant variability
was noted in hospital costs among patients undergoing pa
171 ic antitumor efficacy and prolonged survival
were noted in human orthotopic pancreatic and non-small-
172 No significant effect of PS could
be noted in immediately placed implants.
173 its in respiration and ATP synthase assembly
were noted in individual mutants.
174 The greatest reduction
was noted in infants, with the rotavirus positivity rate
175 No differences
were noted in inflammatory cells in BAL between at-risk
176 009, an outbreak in S. Paratyphi A infection
was noted in Israeli travelers returning from Nepal.
177 Amyloid-related imaging abnormalities
were noted in less than 1% (8/885) of participants.
178 No significant changes
were noted in measures of depression or cocaine craving
179 This association
was noted in men and women, young and old, and white and
180 nuria, no excess risk of atrial fibrillation
was noted in men with type 1 diabetes who had HbA1c lowe
181 ng photoreceptors and retinal ganglion cells
was noted in mice at 12 and 18 months.
182 h normal eyes (P </= 0.003); a similar trend
was noted in mild Fuchs' dystrophy eyes compared with no
183 No difference
was noted in miscarriage in first-line falciparum treatm
184 Symptomatic and survival benefit
is noted in most patients when CaHD is managed by an exp
185 Improvements
were noted in neurologic disability, quality-of-life, an
186 e-assessable patients, an objective response
was noted in nine (18%, 95% CI 9-32) of 49 women with br
187 Positive serotonin release assay
was noted in nine of 11 patients (81.8%) with antiplatel
188 nd Haemophilus influenzae among children has
been noted in numerous studies, as has an inverse relati
189 +) CD4(+) T cells in blood or lamina propria
are noted in patients with CD, and levels directly corre
190 Activation of this system has
been noted in patients with rheumatoid arthritis, and it
191 An increase in challenge threshold to UM
was noted in patients continuing until 12 months (P = .0
192 The lowest risk for loss of kidney function
was noted in patients with BMI of at least 25 kg/m(2) bu
193 gnificant improvement in any sign or symptom
was noted in patients with low baseline SNFL (<16.84 mm/
194 atment groups, although an improvement in OS
was noted in patients with refractory disease treated wi
195 and 84 (P < .05); no significant difference
was noted in patients with SPT III.
196 No differences in any endpoint
were noted in patients with hyperferritinemia at baselin
197 Two dose-limiting toxicities
were noted in patients with myelodysplastic syndrome at
198 Four dose-limiting toxic events
were noted in phase 1: one at a dose of ixazomib of 2.97
199 No dose-limiting toxic effects
were noted in phase 1b.
200 f IL-17A (P = 0.02) and TNF-alpha (P = 0.03)
were noted in PISF when compared with their levels in GC
201 An increased expression of inducible miR-21
was noted in postefferocytotic peripheral blood monocyte
202 6-cKO mice, and some shearing of enamel rods
was noted in posteruption incisors.
203 ayed appearance of the anterior capsule edge
was noted in postoperative visits under slit-lamp examin
204 Impaired terminal differentiation
was noted in primary B cells from patients with KMT2D(Mu
205 Higher prevalence of plaque calcification
was noted in RA, despite similar plaque size (73.3% vs 2
206 A dose-dependent decrease in NO production
was noted in RAW 264.7 macrophages treated with the oil,
207 able for yield traits, although modest gains
were noted in recent years.
208 Only minimal improvements
were noted in response to this evidence-based staff deve
209 longation, arrhythmias, and ischemic changes
were noted in SCA mice before sudden death.
210 11 treatment-emergent serious adverse events
were noted in seven patients (6%) in the pitavastatin gr
211 % of patients was atrial fibrillation, which
was noted in six (12%) patients.
212 Pronounced alterations in B cell development
were noted in SLE in the presence of an IFN signature wi
213 ation of EFS, several fast Ca(2+) transients
were noted in SMCs (rebound excitation).
214 a cells whereas Usp24 protein overexpression
was noted in some patients with drug-refractory myeloma
215 viability and elevated response to stressors
is noted in T150 mutant cells.
216 solution of 58.28 % (RVG) and 58.24 % (CBCT)
was noted in test group when compared to control group.
217 Sample sizes varied between experiments and
are noted in the text.
218 ged a little, whereas a decreasing trend can
be noted in the sham group.
219 Alterations in adult neurogenesis have
been noted in the brain of HIV-infected individuals and
220 Although phenotypic variation has
been noted in the context of antibiotic exposure, no dir
221 ppression of premature mobilization that has
been noted in the context of ovarian tissue transplantat
222 rative action elicited by both catalysts has
been noted in the enantioselective protonation.
223 Ebola virus RNA has
been noted in the following body fluids days or months a
224 ure, a few cases of post-natal survival have
been noted in the literature.
225 This
is noted in the hornworm, Manduca sexta, as a defensive
226 ar association between treatment and outcome
was noted in the 15 recurrent hemolysis events.
227 However, a reduction in all-cause mortality
was noted in the 3 trials using home monitoring (OR: 0.6
228 nter-NICU variation in both composite scores
was noted in the 8 member CQI group.
229 ecular volume [TV]) and trabecular thickness
was noted in the ABBM group at both time points, whereas
230 A failure rate of 30.0%
was noted in the ALPI group compared with 7.5% in the me
231 prostate cancer and hematologic malignancies
was noted in the American Cancer Society prospective coh
232 ulation of CD11c(+)CD11b(+) conventional DCs
was noted in the bulbar conjunctiva and near the limbal
233 low uptake of (125)I-girentuximab-IRDye800CW
was noted in the CAIX-negative SK-RC-59 tumor (4.1 +/- 1
234 ke of (125)I-MOPC21-IRDye800CW (control mAb)
was noted in the CAIX-positive SK-RC-52 tumor (1.2 +/- 0
235 Higher steroid usage
was noted in the CMV positive group compared to age and
236 trial, a 62% relative benefit from baseline
was noted in the E10030 1.5 mg combination therapy group
237 to 71 days (P <.001), and a similar increase
was noted in the entire member VON, 65 to 68 days (P < .
238 apoptosis and in fat infiltration (P < 0.05)
was noted in the exocrine parenchyma of IL-1betaAb-treat
239 posterior reversible encephalopathy syndrome
was noted in the first 6 months.
240 increased in both cohorts, and no difference
was noted in the fold difference of the response between
241 > 0.18 for all), but brighter room lighting
was noted in the homes of participants with higher media
242 significant (P < 0.05) but opposite pattern
was noted in the inner retina (<50% depth).
243 ificant reduction in breast cancer mortality
was noted in the intervention group compared with the co
244 ed ulcer with a peripheral erythematous halo
was noted in the left popliteal fossa; the ulcer had beg
245 mination, significant healing of keratopathy
was noted in the lens group (p = 0.02 and 0.018 for left
246 = 0.18), but a significant decreasing trend
was noted in the modularity of the weighted networks (p
247 the plugs group (p = 0.005); no improvement
was noted in the ocular lubricant group.
248 chy cardiac fibrosis, and hepatic steatosis,
was noted in the other organs.
249 However, no improvement
was noted in the other primary endpoint, overall surviva
250 In contrast, no significant change
was noted in the overall prevalence of JEB or generalize
251 A reduction
was noted in the percentage of postintervention SICU day
252 This
was noted in the porcine SK6 cell line, as well as both
253 r rate of pneumonia-related hospitalizations
was noted in the prasugrel-treated patients when analyse
254 the control group, no significant difference
was noted in the rate of packed red blood cell transfusi
255 tissue mass with internal calcific densities
was noted in the retroperitoneum.
256 acid, lactic acid, and nucleic acid content
was noted in the smoker AgP group compared with the nons
257 ifference, 3.2 days; P = .04); no difference
was noted in the subgroup of infants <4 months old.
258 A palpable mass
was noted in the suprapubic region, and a second mass wa
259 Strong correlation
was noted in the temporal characteristics of Ca(2+) tran
260 overactivation of sphingomyelinase (ASMase)
was noted in the treated cells, indicating participation
261 Improvement
was noted in the UPDRS III motor score 6 months after fi
262 ming units per mL of vaccine-serotype E coli
was noted in the vaccine compared with the placebo group
263 A significant decrease
was noted in the volume of de novo HO present within the
264 No dose-limiting toxicities
were noted in the dose-escalation cohort; on the basis o
265 eased pancreatic lipase amounts and activity
were noted in the extensive visceral fat necrosis of dyi
266 Collagen fibers
were noted in the extracellular matrix.
267 No significant differences
were noted in the frequency of deaths, serious adverse e
268 (arm A), statistically significant increases
were noted in the frequency of grades 1 and 2 edema (P=.
269 ic lesions with strong EBOV antigen staining
were noted in the left eye (scleritis, conjunctivitis, a
270 Poor clinical outcomes
were noted in the majority of patients with primary or s
271 Wide CIs
were noted in the measurement of these factors, probably
272 No differences
were noted in the median daily number of transfused red
273 Transient increases in transaminase levels
were noted in the MK-5172 groups given 400 and 800 mg, a
274 Significant differences
were noted in the molecular profile of unspecified SBA c
275 Few dietary changes
were noted in the MoveMore group over the 6-mo intervent
276 and lower expression of OCN mRNA transcripts
were noted in the PDL-MSCs compared to the P-MSCs.
277 fferences in creatine and glucose metabolism
were noted in the PMC, in contrast to the thalamic and p
278 ingly variable, but the largest growth rates
were noted in the poorest regions.
279 s observed, though significant abnormalities
were noted in the postsynaptic scaffolding protein PSD95
280 No differences
were noted in the rate of positive responses to mannitol
281 No differences
were noted in the rates of 1-year cardiac death (44 [4.0
282 , only trace amounts of mutant ABCA4 protein
were noted in the retina.
283 uring the postintervention period, decreases
were noted in the SICU days related to the most common s
284 Similar trends
were noted in the smaller patient cohort.
285 Specifically, no differences
were noted in the stiffness index, the primary outcome,
286 No major adverse effects
were noted in the studies (aside from minor digestive di
287 Similar reductions in HFH and costs
were noted in the subset of 480 patients with complete d
288 oate group, and 17% in the vilanterol group)
were noted in the treatment groups.
289 fewer UTIs caused by E coli of any serotype
were noted in the vaccine group compared with the placeb
290 itude of maternal DNAemia and pup viral load
were noted in the vaccine groups compared to those in th
291 atients (P = 1.0), as no neurologic sequelae
were noted in this group.
292 Improvement of cranial nerve dysfunction has
been noted in three (30%) of ten children.
293 Grade 3 diarrhoea
was noted in three (9%) of 32 patients; no grade 4 event
294 iven that very little neutrophil recruitment
was noted in thrombocytopenic or CD41-deficient mice.
295 Significant amelioration of weight reduction
was noted in treated mice.
296 (per 10 mm Hg lower systolic blood pressure)
were noted in trials with higher mean baseline systolic
297 DLTs (grade 4 thrombocytopenia)
was noted in two of the patients.
298 While no Abeta deposition
was noted in untreated HSCs of postnatal Abeta precursor
299 surrounding double-strand breaks (DSBs) has
been noted in yeast and mammalian cells but the underlyi
300 reticulum stress and induction of autophagy
were noted in zebrafish larvae and corroborated in 2 mou